Mersana Therapeutics Inc (NASDAQ: MRSN) on Tuesday, soared 4.39% from the previous trading day, before settling in for the closing price of $0.53. Within the past 52 weeks, MRSN’s price has moved between $0.49 and $6.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 15390.52% over the last five years. The company achieved an average annual earnings per share of 58.80%. With a float of $85.06 million, this company’s outstanding shares have now reached $122.87 million.
The firm has a total of 123 workers. Let’s measure their productivity. In terms of profitability, gross margin is 48.0%, operating margin of -228.07%, and the pretax margin is -212.99%.
Mersana Therapeutics Inc (MRSN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mersana Therapeutics Inc is 31.15%, while institutional ownership is 56.53%. The most recent insider transaction that took place on Jan 16 ’25, was worth 2,061. In this transaction VP, Chief Accounting Officer of this company sold 3,554 shares at a rate of $0.58, taking the stock ownership to the 57,519 shares. Before that another transaction happened on Jan 16 ’25, when Company’s Director sold 8,637 for $0.58, making the entire transaction worth $5,009. This insider now owns 168,041 shares in total.
Mersana Therapeutics Inc (MRSN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.21% during the next five years compared to 11.93% growth over the previous five years of trading.
Mersana Therapeutics Inc (NASDAQ: MRSN) Trading Performance Indicators
Mersana Therapeutics Inc (MRSN) is currently performing well based on its current performance indicators. A quick ratio of 2.35 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Mersana Therapeutics Inc (MRSN)
Analysing the last 5-days average volume posted by the [Mersana Therapeutics Inc, MRSN], we can find that recorded value of 5.22 million was lower than the volume posted last year of 7.69 million. As of the previous 9 days, the stock’s Stochastic %D was 13.75%. Additionally, its Average True Range was 0.09.
During the past 100 days, Mersana Therapeutics Inc’s (MRSN) raw stochastic average was set at 2.79%, which indicates a significant decrease from 15.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 108.39% in the past 14 days, which was lower than the 143.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0587, while its 200-day Moving Average is $1.7949. Now, the first resistance to watch is $0.5781. This is followed by the second major resistance level at $0.5997. The third major resistance level sits at $0.6337. If the price goes on to break the first support level at $0.5225, it is likely to go to the next support level at $0.4885. Should the price break the second support level, the third support level stands at $0.4669.
Mersana Therapeutics Inc (NASDAQ: MRSN) Key Stats
Market capitalization of the company is 68.76 million based on 123,533K outstanding shares. Right now, sales total 36,860 K and income totals -171,670 K. The company made 12,600 K in profit during its latest quarter, and -11,500 K in sales during its previous quarter.
